Vanguard Group’s Protagonist Therapeutics PTGX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $241M | Buy |
|
|||||
|
2025
Q1 | $207M | Buy |
|
|||||
|
2024
Q4 | $163M | Buy |
|
|||||
|
2024
Q3 | $190M | Buy |
|
|||||
|
2024
Q2 | $112M | Buy |
|
|||||
|
2024
Q1 | $92.4M | Buy |
|
|||||
|
2023
Q4 | $72.3M | Sell |
|
|||||
|
2023
Q3 | $53.8M | Buy |
|
|||||
|
2023
Q2 | $86.9M | Sell |
|
|||||
|
2023
Q1 | $74.5M | Buy |
|
|||||
|
2022
Q4 | $33.8M | Buy |
|
|||||
|
2022
Q3 | $24.8M | Buy |
|
|||||
|
2022
Q2 | $21.6M | Buy |
|
|||||
|
2022
Q1 | $55.2M | Sell |
|
|||||
|
2021
Q4 | $80.3M | Sell |
|
|||||
|
2021
Q3 | $41.7M | Buy |
|
|||||
|
2021
Q2 | $103M | Buy |
|
|||||
|
2021
Q1 | $55.4M | Buy |
|
|||||
|
2020
Q4 | $40.7M | Buy |
|
|||||
|
2020
Q3 | $30.4M | Buy |
|
|||||
|
2020
Q2 | $25.1M | Buy |
|
|||||
|
2020
Q1 | $7M | Buy |
|
|||||
|
2019
Q4 | $6.98M | Buy |
|
|||||
|
2019
Q3 | $11.2M | Buy |
|
|||||
|
2019
Q2 | $9.69M | Buy |
|
|||||
|
2019
Q1 | $8.79M | Buy |
|
|||||
|
2018
Q4 | $4.44M | Buy |
|
|||||
|
2018
Q3 | $5.46M | Buy |
|
|||||
|
2018
Q2 | $3.48M | Sell |
|
|||||
|
2018
Q1 | $4.51M | Buy |
|
|||||
|
2017
Q4 | $10M | Buy |
|
|||||
|
2017
Q3 | $6.29M | Buy |
|
|||||
|
2017
Q2 | $3.68M | Buy |
|
|||||
|
2017
Q1 | $4.02M | Buy |
|
|||||
|
2016
Q4 | $6.82M | Buy |
|
|||||
|
2016
Q3 | $3.01M | Buy |
|